Risk factors for non-alcoholic fatty liver disease in pregnant women as a basis for in-depth examination and prevention of obstetric complications
Journal of obstetrics and women's diseases · 28.04.2026 · 75 (2) · 42-53
DOI: 10.17816/jowd703096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of obstetrics and women's diseases, online erschienen am 28.04.2026. Verfasst von Elena V. Mozgovaya und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Over the past decade, the incidence of non-alcoholic fatty liver disease (NAFLD) in pregnant women has increased significantly, reaching approximately 10% of all cases; the disease being associated with an increased risk of hypertension, postpartum bleeding, and preterm birth. Pregnant women with NAFLD should be considered a high-risk group due to potential adverse perinatal and obstetric outcomes and potential impact on offspring health. Аim: The aim of this study was to identify NAFLD prevalence and risk factors in patients entering pregnancy. Мethods: This retrospective observational case-control study included data from the medical histories and outpatient records of women who were pregnant between February 2019 and December 2022 (n = 2023). The main group consisted of pregnant women with NAFLD in the first trimester (n = 104), while the remaining pregnant women without a diagnosis of liver or biliary disease were considered the control group. The patients’ blood biochemical parameters were monitored. Additionally, the following were evaluated: the age of pregnant women, the number of pregnancies, the number of fetuses, body weight, body mass index (BMI), bad habits, social status, and the number of previous births. All statistical analyses were performed using MedCalc (version 23.4), Statistica (version 13), and Excel (version 19) software with XRealStats add-ins (version 4.4.1). Statistical significance was determined as a two-sided p value 0.05. Disease prevalence was calculated using the generally accepted formula in Excel (version 19), and the significance of within-group differences was determined between the numbers of patients with or without NAFLD.
Results
NAFLD prevalence in pregnant women in the first trimester was 5.14% (p 0.001). The following risk factors were proven for NAFLD: BMI levels (AUC area = 0.933, maximum value of the Youden index J = 0.7806, associated criterion 27.1); total cholesterol levels (AUC area = 0.945, p 0.001, maximum value of the Youden index J = 0.7655, associated criterion 6.0); smoking (maximum value of the Youden index J = 0.7806, associated criterion 27.1); the number of pregnancies in the anamnesis (β = 0.3257), odds ratio ≈ 1.38.
Conclusion
At the initial visit for pregnancy follow-up, NAFLD incidence was more than 5% in our study. The identified risk factors for NAFLD were elevated BMI and total cholesterol levels, smoking, and history of multiple pregnancies. Such patients should undergo additional examination, including liver ultrasound, lipid profile, and liver function tests, to ensure timely detection and treatment of this condition and reduce the incidence of obstetric complications.
Zitieren
APA
Mozgovaya, E. V., & Kryshnia, M. A. (2026). Risk factors for non-alcoholic fatty liver disease in pregnant women as a basis for in-depth examination and prevention of obstetric complications. Journal of obstetrics and women's diseases, 75(2), 42-53. https://doi.org/10.17816/jowd703096
Vancouver
Mozgovaya EV, Kryshnia MA. Risk factors for non-alcoholic fatty liver disease in pregnant women as a basis for in-depth examination and prevention of obstetric complications. Journal of obstetrics and women's diseases. 2026;75(2):42-53. doi:10.17816/jowd703096
BibTeX
@article{Mozgovaya2026,
author = {Mozgovaya, Elena V. and Kryshnia, Marina A.},
title = {Risk factors for non-alcoholic fatty liver disease in pregnant women as a basis for in-depth examination and prevention of obstetric complications},
journal = {Journal of obstetrics and women's diseases},
year = {2026},
volume = {75},
number = {2},
pages = {42--53},
doi = {10.17816/jowd703096}
}
EUVIMED